By the Numbers
Total active inventions, including copyright and all active sequences, in FY19
Startups created out of UCSF
Total royalty and fee income from UCSF inventions in FY19
Top Inventions, Based on Revenues (FY18)
- Hepatitis B Vaccine (1979, 1981), $8.85 million
- Ablation Device for Atrial Fibrillation (1998), $6.60 million
- Bovine Growth Hormone (1980), $5.00 million
- Sickle Cell Disease Research Tools (2012), $1.83 million